-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented Cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...

Proposes inter-ministry contribution for prioritising the issues   Union Minister of Rural Development Jairam Ramesh has presented a plan to various Central ministries to contribute to the cause of drinking water and sanitation, saying that investment for a healthy population was as important as investing for defence. Mr. Ramesh, who also holds the Drinking Water and Sanitation portfolio, on Tuesday had his proposals ratified at the National Drinking Water and Sanitation Council which...

-AP   Efforts by India and the European Union to strengthen trade are threatening India's ability to deliver lifesaving medicines to the world's poorest, analysts say as the two sides push through protracted negotiations on a free-trade pact.  India's prime minister and top EU officials are hoping their summit Friday in New Delhi helps move beyond disagreements over issues like European labor market limits and Indian duties on cars.  But health industry workers and...

Nearly four years after the High Court mandated reservation of 10 per cent beds and 25 per cent out-patient facilities for the poor in private hospitals in Delhi, only some have complied with the order. As per figures provided by Delhi government in an RTI response to Newsline, none of the major hospitals were able to treat the mandated number of patients. The government received 91 complaints about refusal of treatment...